Truist Financial Cuts Astrana Health (NASDAQ:ASTH) Price Target to $50.00

Astrana Health (NASDAQ:ASTH – Free Report) had its target price trimmed by Truist Financial from $59.00 to $50.00 in a research report released on Monday morning,Benzinga reports. The firm currently has a buy rating on the stock. ASTH has been the subject of a number of other research reports. TD Cowen started coverage on Astrana […]

Leave a Reply

Your email address will not be published.

Previous post ASOS shutters US warehouse as part of cost-saving turnaround plan
Next post Zillow Group (NASDAQ:Z) Given New $75.00 Price Target at Morgan Stanley